| Product Name | Composition | Packing | Pack | MRP | New MRP | Detail |
|---|---|---|---|---|---|---|
| Zincoway | Multivitamin, Multimineral with Grape Seed Extract tab | ALU-ALU | 10*15 | - | Contact | View |
| Rusoviz-F | Rosuvastatin 10mg + Fenofibrate 160mg Tablet | STRIP | 10*10 | - | Contact | View |
| Rusoviz Gold-20 | Rosuvastatin 20 mg + Aspirin 75 mg + Clopidogrel 75 mg capsules | STRIP | 10*10 | - | Contact | View |
| Rusoviz Gold-10 | Rosuvastatin 10 mg + Aspirin 75 mg + Clopidogrel 75 mg capsules | STRIP | 10*10 | - | Contact | View |
| Rusoviz-20 | Rosuvastatin Calcium eq to Rosuvastatin 20 mg Tablet | ALU-ALU | 10*10 | ₹175.00 | ₹164.00 | View |
| Rusoviz-10 | Rosuvastatin I.P 10mg Tablet | ALU-ALU | 10*10 | ₹98.00 | ₹91.00 | View |
| Telniz-Trio | Telmisartan 40mg+ Amlodipine 5mg +Hydrochlorothiazide 12.5 mg | ALU-ALU | 10*15 | ₹145.00 | ₹135.00 | View |
| Telniz-A | Telmisartan & Amlodipine tab IP | ALU-ALU | 10*15 | - | Contact | View |
| Telniz-H | Telmisartan & Hydrochlorothiazide tab IP | ALU-ALU | 10*15 | - | Contact | View |
| Telniz-40 | Telmisartan tab IP 40 mg | ALU-ALU | 10*15 | ₹115.50 | ₹108.00 | View |
| Dapaviz-M | Dapagliflozin 10mg & Metformin 500mg HCL Extended-release tab | ALU-ALU | 10*10 | ₹280.00 | ₹262.00 | View |
| Dapaviz-10 | Dapagliflozin tab 10 mg Tablet | ALU-ALU | 10*14 | ₹275.00 | ₹257.00 | View |
| Sitalyse-M | Sitagliptin (As phosphate) IH 50.0mg & Metformin HCL IP 500.0 mg | BLISTER | 10*15 | ₹240.00 | ₹225.00 | View |
| Vidway-M | Vildagliptin IH 50.0mg & Metformin HCL IP 500.0mg Tab | BLISTER | 10*15 | - | Contact | View |
| Glimway-PM2 | Glimepiride 2mg+Pioglitazone HCL eq. to Pioglitazone 15mg+Metformin HCL 500 mg (extended release) | BLISTER | 10*15 | ₹150.00 | ₹140.00 | View |
| Glimway-PM1 | Glimepiride1mg+Pioglitazone HCL eq. to Pioglitazone 15mg+Metformin HCL 500 mg (extended release) | BLISTER | 10*15 | - | Contact | View |
| Glimway-M2 | Metformin HCL IP 500mg (PR)+Glimepiride 2mg (Bilayred tab) | BLISTER | 10*15 | ₹105.00 | ₹98.44 | View |
| Glimway-M1 | Metformin Hcl Ip 500mg (Pr)+glimepiride 1mg (Bilayred Tab) | BLISTER | 10*15 | - | Contact | View |
The Indian healthcare sector has changed dramatically in the last decade, mainly because of the rising number of chronic diseases from lifestyle changes. Thus, every person involved considers the investment in the cardiac diabetic PCD pharma franchise as the most profitable option. Heart disease and diabetes affect a vast population worldwide. Thus, the requirement for quality medicine at a lower cost reaches peaks each day.
The market for chronic care medications is increasing every year at a rate of more than 12% in the Indian market. Furthermore, investors are looking for reliable associations to partner with them to provide a diversified portfolio of DCGI-approved medications. It is upon this niche that a cardiac and diabetic PCD company can guarantee a steady income source while also satisfying an important social need. Eventually, selecting a specialized portfolio will enable you to establish an excellent reputation with medical professionals.
The majority of the chronic care business essentially tackles long-term health conditions such as Hypertension, Dyslipidemia, and Type 2 Diabetes. Therefore, a cardiac diabetic PCD pharma franchise primarily focuses on life-saving drugs, which patients require daily. These products include anti-hypertensives, statins, oral hypoglycemic agents, and the latest combination therapies.
As these drugs deal with the health of major body parts, they should essentially abide by international standards regarding quality. The already established Indian cardiac and diabetic market, estimated at ₹35,000 crores, continues at an accelerated pace. Further, hectic lifestyles and unhealthy dietary practices have also added to the list of patients. Consequently, the requirement for specialized product solutions makes it effortless for a cardiac diabetic PCD franchise to meet the demands. The appropriate chemical composition and superior packaging guarantee the medications’ efficacy.
The demand for cardiac diabetic products franchise is increasing owing to the alarming rise in non-communicable diseases. As of now, India is being referred to as the “Diabetes Capital of the World,” with about 77 million adults suffering from diabetes. Moreover, the major cause of death in India is attributed to cardiovascular diseases, accounting for about 27% of total deaths. In this manner, the healthcare sector faces a substantial burden in managing this condition.
The demand for preventive medications is also being driven by increased diagnosis and growing health awareness. Since these patients are required to take these medicines throughout their lives, this is an economy- and crisis-proof segment. Thus, most pharmaceutical distributors are relying on the cardiac diabetic PCD pharma franchise to support their business. Additionally, the government’s move to upgrade healthcare in tier-2 and tier-3 cities is presenting an enormous opportunity to expand the franchise model.
Regulation of Blood Glucose Concentrations
Anti-diabetic drugs are a necessary component in keeping the blood sugar level of patients with diabetes in proper form. Specifically, these products can prevent complications such as kidney failure and blindness. In fact, using these high-quality medications helps patients live a normal life.
Hypertension Care
We need cardiac drugs like beta-blockers and ACE inhibitors to control high blood pressure. By easing the strain on the heart and blood vessels, these medications cut down significantly on the risks associated with stroke and heart failure. Consequently, blood pressure management forms the foundation of heart health.
Cholesterol and Lipid Profile Control
These medications provide effective care for high blood cholesterol. In addition to statins, there are various lipid-lowering drugs available. Plus, drugs prescribed for lowering blood cholesterol work to inhibit the buildup of plaques inside the arteries, which can cause heart attacks.
Preventing Blood Clotting
Antiplatelet and anticoagulant medications enable the prevention of life-threatening blood clots. These medications are extremely essential for clients who undergo heart surgery or have heart rhythm disorders. Subsequently, they protect against life-threatening conditions like pulmonary embolism.
Supporting Heart Muscle Function
Advanced cardio formulas are designed to enhance the power of the cardiac muscle and increase blood flow. These medicines are very efficient for those suffering from chronic failure or angina. As a result, patients gain increased levels of energy and an enhanced quality of life.
Getway Healthcare, with our major concentration on quality and innovation, is a leading cardiac and diabetic PCD company. Our company also has a comprehensive product lineup associated with the evolving demands of modern medicine. In addition, our manufacturing process adheres to global safety standards.
By choosing us as your cardiac diabetic PCD pharma franchise provider, you gain all the benefits associated with a well-known brand. We also provide crystal-clear business engagement with guaranteed profit margins to all our associates. Additionally, our advanced logistics system ensures that your order is processed and shipped rapidly. As a result, we assist our partners in dominating their local markets.
Q1. Is a drug license mandatory for a cardiac diabetic franchise?
Yes, a valid Wholesale Drug License and GST Registration are the legal compulsions for conducting pharmaceutical distribution in India.
Q2. What profit margins can I expect from a cardiac and diabetic PCD company?
Typically, the profit margins may run between 15% and 25%, depending on the specific sales volume and product categories.
Q3. Does Getway Healthcare offer exclusive territory rights?
Yes, we provide exclusive monopoly rights for a particular geographical area, ensuring no internal brand competition in your zone.